Cystoisospora suis (Neonatal Coccidiosis)
LEVELS: Highly unlikely: No controls necessary; Highly unlikely: No evidence of non-foodborne zoonotic transmission; Highly effective: Routine on-farm biosecurity measures are effective in preventing farm-to-farm transmission; Moderate: Clinical signs not unique but existing tests available at local/regional laboratory(s); Substantial: Unsustainable acute or chronic losses related to severe clinical signs in a high prevalence of animals; Negligible: Little or no market disruption when disease occurs on one or more farms; Minimal risk: Agent inherently unlikely to develop clinically important resistance to antibacterial or antiviral treatments; Minimal risk: Antibacterial or antiviral treatments rarely occur, or are typically limited to short-course individual animal therapy; Available but with uncertain efficacy: Limited treatments available in US or are only effective in some situations; No availability: Effective vaccines not currently available in the US (or have not been developed); Possible: Eradication possible but likely to require major changes into logistic systems, regulatory environment, infrastructure, and producer behaviors
Criteria Levels
- Foodborne Zoonotic Transmission: No evidence of transmission
- Non-Foodborne Zoonotic Transmission: No evidence of transmission
- Beyond-Farm Spread Potential: Farm biosecurity effective
- Detection Difficulty: Moderate: confirmation once suspected
- Financial Impact - Mortality and Morbidity Costs: Substantial ongoing losses
- Financial Impact - Prevention and Control Costs: Little market disruption
- Antimicrobial Resistance - Pathogen Risk: Low resistance risk
- Antimicrobial Resistance - Treatment Impact: Minimal: Rare or short-course individual treatments
- Treatment Availability: Effective in some situations
- Vaccine Availability: No effective vaccine or bacterin available
- Eradication Feasibility: Feasible but requires major investment of time and/or money
Overview
Cystoisospora suis (synonym Isospora suis) causes the most important protozoal disease of swine - neonatal piglet coccidiosis. First recognized as a clinical problem in the mid-1970s, it has cosmopolitan distribution wherever pigs are raised in confinement. The parasite causes yellowish to grayish diarrhea in nursing pigs 7-14 days of age, leading to dehydration, rough hair coats, and depressed weight gains. Morbidity is high but mortality usually moderate. The warm, moist environment of farrowing crates (32-35°C) favors rapid oocyst sporulation within 12 hours, perpetuating infection cycles.
Detailed Justification
1. Foodborne Zoonotic Transmission
Level: No evidence of transmission
C. suis is a host-specific swine coccidian with no documented foodborne transmission to humans. The parasite completes its entire life cycle in the pig intestinal epithelium. There is no mechanism for foodborne human infection.
2. Non-Foodborne Zoonotic Transmission
Level: No evidence of transmission
C. suis is strictly host-specific to swine. The chapter makes no mention of human infection or zoonotic potential. Coccidia of the Cystoisospora genus are generally host-restricted.
3. Beyond-Farm Spread Potential
Level: Farm biosecurity effective
The primary source of infection is the farrowing facility environment, not incoming animals: - "The source of clinical Cystoisospora infections in nursing pigs is most likely from residual oocysts in the environment of the farrowing facility rather than sow's feces" - Sows rarely excrete C. suis oocysts (<3% in surveys) - "Once C. suis becomes established on a farm, it is probably transmitted through contaminated farrowing crates"
Standard biosecurity preventing introduction of infected animals, combined with sanitation protocols, can prevent establishment. The organism does not spread via aerosol or vectors.
4. Detection Difficulty
Level: Moderate: confirmation once suspected
Clinical suspicion is straightforward, but confirmation requires laboratory work: - "Diarrhea in nursing pigs 7-14 days of age that does not respond to antibiotic treatment is suggestive" - Diagnosis requires finding oocysts in feces or developmental stages in tissue - "Fecal smears or fecal flotations should be from several litters... because diarrhea starts around a day before oocysts are excreted" - "Piglets excrete oocysts in several phases and may be negative during these phases" - PCR assays available but not routine
The timing of sample collection relative to clinical signs and the intermittent shedding pattern complicate diagnosis.
5. Financial Impact - Mortality and Morbidity Costs
Level: Substantial ongoing losses
The disease causes significant ongoing production impacts: - "Morbidity is high, but mortalities are usually moderate" - "Affected pigs often have loss of body condition with reduced growth rates, which may impact postweaning performance" - Endemic in most herds: "Since C. suis is endemic in most herds, mere detection confirms the presence of infection" - Variable severity: "Litters within the farrowing house vary in the degree to which they develop clinical signs"
This represents ongoing, herd-wide production losses affecting multiple farrowing groups.
6. Financial Impact - Prevention and Control Costs
Level: Little market disruption
Neonatal coccidiosis is not a regulated disease. There are no trade restrictions, slaughter surveillance requirements, or market access issues. Economic impact is limited to direct production losses and treatment/prevention costs.
7. Antimicrobial Resistance - Pathogen Risk
Level: Low resistance risk
C. suis is a protozoan parasite treated with anticoccidial drugs (toltrazuril), not antibiotics. Traditional AMR concerns do not apply. However, the chapter notes: "Improper dosing can result in drug resistance to toltrazuril" - this is antiparasitic resistance rather than antimicrobial resistance relevant to the One Health framework.
8. Antimicrobial Resistance - Treatment Impact
Level: Minimal: Rare or short-course individual treatments
Treatment is with toltrazuril (an anticoccidial), not antibiotics. There is no antimicrobial selection pressure from coccidiosis treatment. Antibiotic use may occur for secondary bacterial infections but is not the primary intervention.
9. Treatment Availability
Level: Effective in some situations
Toltrazuril is effective but has limitations: - "Toltrazuril is an effective means of treating coccidiosis in nursing piglets" - "A single dose of 20 mg/kg given at 3 days of age has been shown to decrease clinical signs and be cost effective" - "Controlled studies conducted to date in nursing pigs have not identified other effective coccidiostats"
The limitation is that treatment must be given prophylactically (day 3) before clinical signs appear, and improper dosing can lead to resistance. Treatment of clinically affected pigs is less effective than prevention.
10. Vaccine Availability
Level: No effective vaccine or bacterin available
No vaccine is mentioned. Control relies on: - Toltrazuril prophylaxis - Sanitation programs - Environmental management
11. Eradication Feasibility
Level: Feasible but requires major investment of time and/or money
Eradication is possible but requires intensive, sustained effort: - "Improved attention to sanitation has been the most successful method for reducing losses" - "A good sanitation program entails thorough cleaning of the crates to remove organic debris, disinfection, and steam cleaning" - "In extreme cases, sealing or painting solid surfaces within farrowing crates can help break the cycle" - "Once the oocysts are sporulated, they are resistant to most disinfectants" - "Producers should be made aware that even though clinical disease is under control, the potential for future outbreaks is still present"
The environmental persistence of sporulated oocysts and their resistance to disinfectants makes eradication challenging but achievable with sustained investment in sanitation infrastructure and protocols.
Summary
Cystoisospora suis causes neonatal coccidiosis, the most important protozoal disease of swine worldwide. Affecting nursing pigs 7-14 days of age, it causes yellowish diarrhea, dehydration, and reduced growth rates with high morbidity but usually moderate mortality. The warm, moist farrowing environment favors rapid oocyst sporulation. Sows are not the primary source - environmental contamination of farrowing crates perpetuates infection. Diagnosis requires demonstration of oocysts or tissue stages, complicated by intermittent shedding. Toltrazuril given prophylactically at 3 days of age is effective, though resistance can develop with improper dosing. No vaccine exists. Control depends on intensive sanitation programs, which can reduce but not easily eliminate the parasite due to oocyst environmental resistance.